Using Ac4GalNAz (T304292) in Metabolic Glycan Labeling Protocols

1,3,4,6-Tetra-O-acetyl-2-[(azidoacetyl)amino]-2-deoxy-β-D-galactopyranos is a cell-permeable, peracetylated azide-functionalized GalNAc analog (Ac4GalNAz) that is metabolically incorporated into cellular O-GalNAc glycoproteins and mucin-type glycans, enabling subsequent bioorthogonal ligation with alkyne or phosphine probes for visualization, enrichment, and proteomic profiling of glycosylated proteins.

Chemical Name

1,3,4,6-Tetra-O-acetyl-2-[(azidoacetyl)amino]-2-deoxy-β-D-galactopyranose (Ac4GalNAz)

SKU

T304292

Mechanism

Peracetyl groups enable passive cell permeability; intracellular esterases cleave acetates to release free GalNAz, which enters the GalNAc salvage pathway and is incorporated into O-linked glycans via UDP-GalNAz.

Bioorthogonal Handle

Azide (–N₃) group on the C2-acetamide; reacts with strained alkynes (SPAAC) or terminal alkynes (CuAAC), and with Staudinger phosphine reagents.

Primary Applications

Metabolic glycan labeling, O-GalNAc glycoprotein detection and enrichment, flow cytometry, fluorescence microscopy, and glycoproteomic mass spectrometry.

Recommended Working Concentration

Typically 25–100 µM in cell culture medium; optimal concentration should be determined empirically for each cell line.

Storage

Store at –20 °C, protected from light and moisture; prepare stock solutions in anhydrous DMSO.

Reagent Overview and Mechanism of Action

1,3,4,6-Tetra-O-acetyl-2-[(azidoacetyl)amino]-2-deoxy-β-D-galactopyranose, commonly abbreviated Ac4GalNAz (Aladdin Scientific SKU: T304292), is a synthetic, peracetylated monosaccharide analog designed for metabolic glycan labeling (MGL). The four acetyl groups mask the hydroxyl functionality of the galactosamine core, conferring passive membrane permeability so the compound enters cells without requiring active transport.

Once inside the cell, cytosolic and lysosomal esterases hydrolyze the acetate esters to liberate free GalNAz. This free sugar is then phosphorylated and converted to UDP-GalNAz by the enzymes of the GalNAc salvage pathway (GalK, GalPUT, and AGX1/2). UDP-GalNAz serves as a substrate for GalNAc transferases (GalNAc-Ts), which transfer GalNAz onto serine and threonine residues of acceptor proteins, installing the azide handle into newly synthesized O-GalNAc glycoproteins and mucin-type glycans.

The azide group is chemically inert under physiological conditions and absent from native mammalian biochemistry, making it an ideal bioorthogonal reporter. Azide-labeled glycoproteins can subsequently be detected, imaged, or enriched by reaction with complementary bioorthogonal probes including: (1) Cu(I)-catalyzed azide–alkyne cycloaddition (CuAAC) using terminal alkynes; (2) strain-promoted azide–alkyne cycloaddition (SPAAC) using dibenzocyclooctyne (DBCO) or bicyclononyne (BCN) probes (copper-free, suitable for live cells); and (3) Staudinger ligation using triarylphosphine-FLAG or phosphine-biotin conjugates.

Materials and Stock Solution Preparation

Materials Required

• Ac4GalNAz (T304292, Aladdin Scientific)
• Anhydrous dimethyl sulfoxide (DMSO), cell-culture grade
• Serum-free or complete cell culture medium appropriate for your cell line
• Sterile 1.5 mL microcentrifuge tubes
• Bioorthogonal detection reagents (e.g., DBCO-fluorophore for SPAAC, alkyne-biotin for CuAAC)
• Cell lysis buffer (for downstream proteomics or Western blotting)

Preparing the DMSO Stock Solution

1. Allow the vial of Ac4GalNAz (T304292) to equilibrate to room temperature inside a desiccator before opening, to prevent condensation.
2. Dissolve the compound in anhydrous DMSO to prepare a 20–50 mM stock solution. Vortex gently until fully dissolved.
3. Aliquot into single-use volumes (e.g., 10–20 µL per tube) in amber or foil-wrapped microcentrifuge tubes to minimize freeze–thaw cycles and light exposure.
4. Store aliquots at –20 °C. Stocks prepared in anhydrous DMSO are generally stable for several months when stored properly.

Note: The final DMSO concentration in cell culture medium must not exceed 0.1–0.2% (v/v) to avoid cytotoxicity. Prepare working solutions by diluting stock directly into pre-warmed medium immediately before use.

Step-by-Step Metabolic Labeling Protocol

This protocol describes metabolic incorporation of Ac4GalNAz into adherent mammalian cell lines followed by bioorthogonal detection via SPAAC (copper-free, suitable for live-cell imaging) or CuAAC (for fixed cells and lysates).

Day 1 – Cell Seeding

1. Seed cells at an appropriate density in the chosen vessel (e.g., 6-well plate, 10 cm dish, or chambered coverslip for imaging) in complete growth medium.
2. Allow cells to adhere and recover overnight (16–18 h) in a humidified incubator at 37 °C, 5% CO₂.

Day 2 – Ac4GalNAz Treatment

1. Prepare working solution: dilute DMSO stock of Ac4GalNAz (T304292) in pre-warmed complete medium to the desired final concentration (starting recommendation: 50 µM; test range 25–100 µM). Final DMSO ≤ 0.1%.
2. Remove spent medium from cells; add Ac4GalNAz working solution.
3. Incubate for 24–72 hours at 37 °C, 5% CO₂. Longer incubation times generally yield higher levels of glycan labeling; optimize for your cell type.
4. Include a vehicle control (DMSO at matching concentration without Ac4GalNAz) and, where possible, a negative-sugar control (e.g., peracetylated glucose analog) to assess non-specific background.

Day 3 or 4 – Bioorthogonal Detection (SPAAC, Live Cells)

1. Aspirate Ac4GalNAz medium. Wash cells gently 3× with PBS (37 °C).
2. Prepare DBCO-fluorophore working solution in serum-free medium at the manufacturer's recommended concentration (typically 10–25 µM).
3. Add DBCO-fluorophore solution to cells and incubate at 37 °C for 30–60 min.
4. Wash 3× with PBS to remove unreacted probe.
5. Proceed to imaging (confocal or widefield fluorescence microscopy) or flow cytometry analysis.

Alternative: CuAAC Detection in Cell Lysates

1. After Ac4GalNAz treatment, lyse cells in RIPA or NP-40 lysis buffer supplemented with protease inhibitors.
2. Clarify lysate by centrifugation (14,000 × g, 10 min, 4 °C).
3. Perform CuAAC click reaction: combine lysate with alkyne-biotin probe, CuSO₄, THPTA ligand, sodium ascorbate, and aminoguanidine as per established CuAAC protocols.
4. Quench reaction; analyze by SDS-PAGE and streptavidin-HRP Western blot, or enrich glycoproteins with streptavidin-agarose for proteomic MS analysis.

Troubleshooting and Optimization Tips

Problem	Likely Cause	Recommended Action
Low or absent labeling signal	Insufficient Ac4GalNAz concentration or incubation time; poor cell uptake	Increase concentration stepwise (25 → 50 → 100 µM) and/or extend incubation to 72 h; verify cell viability is not compromised
High background signal	Incomplete washing; non-specific probe binding; non-bioorthogonal reaction	Increase PBS wash steps to 5×; titrate down detection probe concentration; ensure DMSO vehicle control is included
Cell toxicity	Excessive DMSO or Ac4GalNAz concentration	Keep DMSO ≤ 0.1% (v/v); reduce Ac4GalNAz to 25 µM; perform MTT or trypan blue viability assay at each concentration tested
Inconsistent results between experiments	Freeze–thaw degradation of stock; variation in cell passage number	Use single-use aliquots; work with cells within a defined passage number range; confirm stock integrity by TLC or LC-MS if available
No signal in CuAAC experiment	Cu(I) oxidation; insufficient ascorbate; ligand absent	Prepare fresh Cu(I) catalyst; use THPTA or BTTAA ligand; add aminoguanidine to scavenge reactive oxygen species

Important: For live-cell applications, always prefer SPAAC (DBCO or BCN probes) over CuAAC, as Cu(I) is cytotoxic. CuAAC is best reserved for fixed cells, cell lysates, and in vitro reactions.

Safety, Handling, and Regulatory Notes

Ac4GalNAz (T304292) is an organic azide-containing research reagent. Observe the following precautions:

• Azide safety: Organic azides can be thermally labile at high temperatures or when in contact with strong acids. Avoid heating bulk quantities, contact with concentrated acids, or heavy-metal contamination, which can catalyze decomposition. At the milligram scale used in research, the compound presents low acute hazard, but standard laboratory PPE (lab coat, nitrile gloves, safety glasses) should be worn.
• DMSO handling: DMSO rapidly penetrates skin and can carry dissolved solutes transdermally. Wear appropriate chemical-resistant gloves when handling DMSO stocks.
• Disposal: Dispose of azide-containing waste according to institutional and local regulations. Do not pour azide solutions down metal drains without appropriate decontamination, as metal azides can accumulate and pose explosion risk.
• Research use only: This product is for in vitro research use only and is not approved for diagnostic or therapeutic use in humans or animals.
• SDS: Consult the Safety Data Sheet provided by Aladdin Scientific for complete hazard information before use.

Frequently asked questions

What is the difference between Ac4GalNAz and GalNAz, and why use the peracetylated form?

GalNAz (free azido galactosamine) has limited cell permeability due to its polar hydroxyl groups, requiring active transport and resulting in lower and more variable intracellular accumulation. Ac4GalNAz bears four acetyl groups that mask these hydroxyls, enabling passive diffusion across the plasma membrane. Once inside the cell, cytosolic esterases remove the acetates to yield free GalNAz, which enters the biosynthetic pathway. The peracetylated form therefore typically achieves more efficient and reproducible metabolic labeling at lower concentrations.

Can Ac4GalNAz label N-linked glycans in addition to O-linked glycans?

Ac4GalNAz is primarily incorporated into O-GalNAc-type glycans (mucin-type O-glycosylation) because GalNAc transferases that initiate O-glycosylation utilize UDP-GalNAz as a substrate. N-linked glycosylation uses GlcNAc rather than GalNAc at its core, and while some cross-labeling of other pathways is possible due to epimerization by cellular enzymes, the predominant labeling observed with Ac4GalNAz targets O-linked glycoproteins. Researchers seeking to specifically label O-GlcNAc modifications should use the corresponding Ac4GlcNAz analog instead.

How long should cells be incubated with Ac4GalNAz for optimal labeling?

Incubation periods of 24 to 72 hours at 37 °C are commonly used, with longer times generally producing stronger labeling signal due to greater cumulative incorporation into newly synthesized glycoproteins. The optimal duration depends on the cell line, rate of glycoprotein turnover, and the specific glycoproteins of interest. A time-course experiment (24 h, 48 h, 72 h) is recommended when working with a new cell line to determine the optimal window before significant cytotoxicity or medium depletion becomes a concern.

Is Ac4GalNAz suitable for in vivo glycan labeling experiments?

Ac4GalNAz has been used in various in vivo settings (e.g., zebrafish, mouse models) by systemic administration to label glycans in living organisms, as described in the bioorthogonal chemistry literature. However, in vivo applications require careful dose optimization, toxicity assessment, and consideration of tissue distribution and metabolic fate. T304292 from Aladdin Scientific is supplied as a research-grade reagent; researchers planning in vivo studies must perform their own safety and feasibility assessments and comply with all applicable institutional animal use regulations.

References

1. Hang HC, Yu C, Kato DL, Bertozzi CR. A metabolic labeling approach toward proteomic analysis of mucin-type O-linked glycosylation. Proc Natl Acad Sci USA. 2003;100(25):14846–14851. doi:10.1073/pnas.2335201100
2. Prescher JA, Bertozzi CR. Chemistry in living systems. Nat Chem Biol. 2005;1(1):13–21. doi:10.1038/nchembio0605-13
3. Sletten EM, Bertozzi CR. Bioorthogonal chemistry: fishing for selectivity in a sea of functionality. Angew Chem Int Ed. 2009;48(38):6974–6998. doi:10.1002/anie.200900942
4. Saxon E, Bertozzi CR. Cell surface engineering by a modified Staudinger reaction. Science. 2000;287(5460):2007–2010. doi:10.1126/science.287.5460.2007

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.